Michael F Cola's Net Worth

-$570 Thousand

Estimate Recalculated Apr 10, 2024 03:32PM EST

Who is Michael F Cola?

Michael F Cola does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include NUPATHE INC., Phathom Pharmaceuticals, Inc., Vanda Pharmaceuticals Inc., Sage Therapeutics, Inc., Avalo Therapeutics, Inc., Aevi Genomic Medicine, LLC, SAFEGUARD SCIENTIFICS INC, and CLARIENT, INC.

SEC CIK

Michael F Cola's CIK is 0001188940

Past Insider Trading and Trends

2020 was Michael F Cola's most active year for acquiring shares with 9 total transactions. Michael F Cola's most active month to acquire stocks was the month of May. 2014 was Michael F Cola's most active year for disposing of shares, totalling 23 transactions. Michael F Cola's most active month to dispose stocks was the month of January. 2015 saw Michael F Cola paying a total of $1,268,105.86 for 359,469 shares, this is the most they've acquired in one year. In 2014 Michael F Cola cashed out on 152,314 shares for a total of $574,324.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NUPATHE INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-13.50K
$6.80
-$91,800.00
0
Feb 21
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 5
Form 4
∞
13.5K
—
—
13.5K
Apr 24
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Jun 30
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Mar 31
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Sep 30
Form 4
—
0
—
—
0
Mar 31 - Jun 30
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Mar 3
Form 3
—
0
—
—
0
No matching records found

Phathom Pharmaceuticals, Inc. (PHAT) Snapshot price: $7.04

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+91.86%
9K
—
—
18.8K
May 25
Form 4
—
0
—
—
0
May 25
Form 4
∞
9.8K
$19.00
$186,162.00
9.8K
Oct 29
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 21
Form 3
—
0
—
—
0
No matching records found

Vanda Pharmaceuticals Inc. (VNDA) Snapshot price: $3.625

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+50.00%
5K
—
—
15K
Jun 13
Form 4
+100.00%
5K
—
—
10K
Jun 13
Form 4
∞
5K
—
—
5K
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 18
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
Jun 20
Form 4
—
0
—
—
0
Jun 14
Form 3
—
0
—
—
0
No matching records found

Sage Therapeutics, Inc. (SAGE) Snapshot price: $23.97

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Jun 16
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Sep 11
Form 3
—
0
—
—
0
No matching records found

Avalo Therapeutics, Inc. (AVTX) Snapshot price: $4.34

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Apr 1
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Oct 1
Form 4
—
0
—
—
0
Jul 1
Form 4
—
0
—
—
0
Jun 18
Form 4
+132.02%
100K
$2.50
$250,000.00
175.75K
Jun 9
Form 4
∞
75.75K
—
—
75.75K
Feb 3
Form 3
—
0
—
—
0
No matching records found